How thyroid cancer is misdiagnosed or diagnosed late in Ireland

Thyroid cancer is uncommon and usually painless, so the first sign is most often a lump in the neck or a thyroid nodule found by chance. The Irish Cancer Society [01] reports around 280 people are diagnosed each year, more often women and people over 40, with incidence rising in younger adults per National Cancer Registry Ireland [02] data.

The expected Irish pathway for a suspicious nodule is reasonably clear. A GP typically requests a blood test for thyroid stimulating hormone (TSH), arranges a neck ultrasound, and refers for a fine needle aspiration (FNA) biopsy where the ultrasound features or size call for one. Ultrasound risk is commonly graded using the European Thyroid Association EU-TIRADS system, and biopsy results are graded using the Bethesda system. A correct diagnosis usually depends on all three working together, the clinical examination, the imaging and the cytology, an approach clinicians call the triple assessment.

One feature of the Irish system matters a great deal for these claims. The HSE National Cancer Control Programme operates Rapid Access Clinics and a national GP electronic-referral pathway for a small number of cancers, breast, lung, prostate and melanoma (HSE NCCP GP referral guidelines [03]). There is no equivalent rapid-access clinic for thyroid cancer. A patient with a worrying neck lump therefore relies on the GP recognising the red flags and making a timely urgent referral to endocrinology or ENT. When that judgement fails, no national fast-track exists to catch the error.

Common ways the diagnosis is missed

Across thyroid cases the same patterns recur. Each one can amount to negligence where a reasonable practitioner would have acted differently.

1. A neck lump assumed to be a benign goitre. A nodule is felt but treated as harmless without an ultrasound or referral, particularly in younger women, who are wrongly seen as low risk.
2. Normal thyroid bloods treated as an all-clear. A normal TSH result doesn't rule out cancer. Most thyroid cancers don't change hormone levels at all, so a false all-clear from normal bloods is a frequent error.
3. Ultrasound findings not acted on. Under the EU-TIRADS system a biopsy is generally advised for an intermediate-risk nodule above 15mm and a high-risk nodule above 10mm (European Thyroid Association EU-TIRADS [04]). Failing to arrange an FNA for a nodule that met the threshold is a clear point of failure.
4. An inconclusive or falsely negative biopsy left unrepeated. A thyroid FNA sample can be inadequate, and a benign result can still be a false negative. In a large Irish series that false-negative rate was low but not zero, so a repeat biopsy is advised where the nodule stays suspicious on ultrasound (Irish FNA series [05]). Accepting a single poor sample without safety-netting can let a cancer progress.
5. A Bethesda III result discharged without follow-up. An atypia of undetermined significance result calls for a repeat biopsy, molecular testing or active surveillance. Sending the patient away with no plan is a recognised failure mode.
6. An incidental nodule on a scan ignored. A nodule reported on a CT or MRI done for another reason is sometimes never followed up by the referring clinician. See test results not followed up.
7. Red-flag symptoms blamed on something else. Hoarseness, a change in voice, difficulty swallowing or a hard, fixed lump with enlarged neck glands are attributed to reflux, a viral illness or stress instead of prompting urgent referral. See failure to refer.

The thread running through these failures is safety-netting. Safety-netting, sometimes called closing the loop or failsafe follow-up, is the recognised practice of making sure an uncertain result is chased, the patient is told what to watch for, and someone owns the next step. When an inadequate biopsy, a Bethesda III result or an incidental nodule is left without a clear plan, the loop stays open and a cancer can grow unnoticed. A failure to safety-net is often the clearest breach in a thyroid claim.

What most thyroid pages get wrong

Three myths cause people with a real claim to talk themselves out of it.

Proving negligence: breach of duty and causation

An Irish thyroid claim has to clear two separate hurdles, and both must be proven on the balance of probabilities.

Breach of duty is judged by the Dunne test from Dunne v National Maternity Hospital, the standard the Supreme Court reaffirmed in Morrissey v HSE. A GP, radiologist, endocrinologist or pathologist is negligent only where they did something no responsible practitioner of equal standing would have done. Applied to thyroid care, that means asking whether a competent clinician would have arranged the ultrasound, ordered the FNA the EU-TIRADS grade required, repeated an inadequate sample, or acted on a Bethesda III result. Our page on causation in medical negligence sets out the test in full.

Causation is usually where these cases are fought. The State Claims Agency often accepts that an error occurred while arguing it made no difference to the outcome. Because thyroid cancer survival is generally high, that argument carries real weight, so the medical evidence has to show what the delay actually changed. Most claims need two expert reports, one on breach and one on causation, and to avoid conflicts within a small medical community the causation expert is frequently instructed from the United Kingdom.

Some claims also raise a consent point. Where a delay forces a larger operation and the surgeon doesn't warn of the heightened risk to the voice box nerve, a separate claim for failure to advise on a material risk can arise, following Fitzpatrick v White. That overlaps with our work on nerve damage after surgery.

Irish cases that shape these claims

Two Supreme Court decisions do most of the work in a thyroid delay claim.

Case law is summarised for general information. The relevance of any decision depends on the facts of your case.

Loss of chance: did the delay reduce your survival or treatment options?

Loss of chance is the heart of most thyroid claims, and Irish law accepts it as a compensable injury. In Philp v Ryan the Supreme Court allowed damages for a lost treatment opportunity even though the patient could not prove the delay would, on its own, have changed survival. You don't have to show you would have died. You have to show the delay took away a real and measurable chance of a better course.

In thyroid cancer that lost chance is often about treatment rather than life expectancy. Caught early, a differentiated thyroid cancer may be treated with removal of half the gland. A delayed diagnosis frequently means the whole gland must be removed, often with a neck dissection to clear affected lymph nodes, followed by radioactive iodine therapy. The escalation brings real and sometimes permanent harm:

• injury to the recurrent laryngeal nerve, causing a hoarse or weak voice and, at worst, breathing difficulty
• damage to the parathyroid glands, leaving low calcium that needs lifelong treatment
• a lifetime of thyroid hormone replacement and regular monitoring
• a permanent neck scar and significant psychological distress

The subtype of cancer also shapes how strong the causation argument is. The figures below are general survival statistics, not a prediction for any individual case, and outcomes vary.

Survival and frequency figures are drawn from international clinical sources including the Merck Manual [07] and are general statistics only.

Medullary thyroid cancer deserves a separate word. It is uncommon, but it produces a hormone called calcitonin, and a raised calcitonin level can flag it early. Where there is a family history or a suspicious nodule, not measuring calcitonin can be a distinct failure, because medullary cancer is more aggressive than the common papillary type and a delay matters more. It can also be hereditary, linked to a change in the RET gene and to the MEN2 syndromes, so a missed diagnosis can delay the screening that would protect a patient's relatives.

The strongest claims tend to involve an aggressive subtype, a clear shift to a later stage during the delay, or a documented escalation in treatment. Where the cancer was an indolent papillary type that would have behaved the same way regardless, the claim may rest on the avoidable extra surgery and its consequences rather than on survival. An honest assessment of which applies is part of what we do.

A common defence argument deserves naming. Small papillary thyroid cancers are now found far more often than before, and many would never have caused harm in a person's lifetime, so the State Claims Agency may argue that a delay changed nothing. That argument can be met, but only with evidence, by showing the tumour grew or spread during the delay, that treatment had to escalate, or that the cancer was not the indolent kind. A careful causation opinion is what makes the difference.

Compensation: what a claim may include

Compensation in Irish clinical negligence has two parts. Any figures here are illustrative and depend entirely on the facts.

General damages cover pain, suffering and loss of amenity, such as the extra surgery, a neck scar, voice or calcium problems, and psychological harm. The courts assess these using the Personal Injuries Guidelines [08], which set a ceiling of about €550,000 for the most catastrophic injuries (Judicial Council, 2021 Guidelines, in force as of June 2026, awards vary case by case). A proposed increase to about €642,000 was put forward in 2025 but has not been enacted. The Guidelines are binding, so following the Supreme Court in Delaney v PIAB [2024] IESC 10 any change to these figures must be made by the Oireachtas. Thyroid cases rarely sit near that ceiling. They are valued by reference to the dominant injury, so a clinical case doesn't map neatly onto a single road-traffic style bracket. Our general damages page explains how this works.

Special damages have no cap. They cover financial losses you can prove, such as the cost of extra scans, further surgery and radioactive iodine, lost earnings during a longer treatment and recovery, future monitoring, and any care you needed. In more serious cases these can far exceed the general damages.

Where a delay or treatment failure proves fatal, which is most likely with anaplastic or poorly differentiated cancer, the family may bring a claim. The Civil Liability Act 1961 [13] provides for the dependants' financial loss together with a fixed statutory payment for mental distress, currently €35,000, divided among the dependants. Our fatal injury claims page covers this route.

Thyroid cancer care has already been litigated in Ireland. In a High Court case taken by the family of Eileen Hyland against the HSE over care at Cork University Hospital, it was alleged that a patient on dialysis was wrongly advised that radioactive iodine therapy was unavailable to her and was not referred to a centre where it could be given. The case settled without admission of liability, and the hospital later began providing the therapy for dialysis patients (reported by The Irish Times [09]). It shows that treatment and advice failures around thyroid cancer, not only diagnostic delay, can found a claim.

Time limits and date of knowledge

The general rule is two years less one day to start court proceedings. That two-year period comes from section 7 of the Civil Liability and Courts Act 2004 [11], and it runs from your date of knowledge, defined by section 2 of the Statute of Limitations (Amendment) Act 1991 [10] as the point at which you first knew, or ought reasonably to have known, that a significant injury was caused by negligent care.

For a slow-growing thyroid cancer this date can fall well after the original appointment, sometimes only when a later scan, second opinion or set of records reveals that an earlier nodule should have been investigated. Two further points matter. Medical negligence is exempt from the Injuries Resolution Board, so unlike most injury claims, lodging there does not pause time, and only issuing High Court proceedings stops the clock. For children, the clock does not start until their eighteenth birthday. A proposed three-year period under section 221 of the Legal Services Regulation Act 2015 has never been commenced, so the two-year rule still applies. Our medical negligence time limits page covers the exceptions, and because the date of knowledge is a legal judgment, confirming yours early is worthwhile.

How you find out can matter too. Since 26 September 2024, the Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 [12] has required health services to tell patients, or their families, about certain serious patient-safety incidents, with an apology where appropriate. Where a delayed diagnosis is disclosed in this way, that meeting can be the moment you learn earlier care fell short, which may mark your date of knowledge for the time limit. The Supreme Court in Morrissey v HSE also treated open disclosure as part of proper care.

How a thyroid cancer misdiagnosis claim works

Most thyroid claims in Ireland follow the same path, and knowing the steps makes the process less daunting.

1. Free, confidential review. We listen to what happened and explain whether it's worth investigating, at no cost.
2. Gathering your records. We'll request your GP, hospital, radiology and pathology records to build a clear timeline.
3. Independent expert reports. We instruct specialists to say whether the care fell below the Dunne standard and whether the delay caused harm, the two things every claim must prove.
4. Issuing proceedings. Because medical negligence is exempt from the Injuries Resolution Board, the claim is issued in the High Court within the time limit.
5. Settlement or hearing. Many claims settle once the evidence is exchanged. Where no fair offer is made, the case proceeds to a hearing.

Key thyroid claim terms explained

Thyroid nodule

A lump in the thyroid gland. Most are harmless, but a minority are cancerous, which is why a suspicious nodule should be investigated.

EU-TIRADS

A European scoring system that grades a thyroid nodule on ultrasound and sets the size at which a biopsy is advised.

Fine needle aspiration (FNA)

A thin-needle biopsy that takes a sample of cells from a nodule for testing.

Bethesda system

The scale used to report an FNA result, running from clearly benign to clearly cancerous, with uncertain categories in between.

Total and partial thyroidectomy

Surgery to remove all or part of the thyroid gland. A delayed diagnosis often forces the larger, total operation.

Recurrent laryngeal nerve

The nerve to the voice box, which runs beside the thyroid and can be injured during surgery, affecting the voice.

Hypoparathyroidism

Low calcium caused by damage to the parathyroid glands during thyroid surgery, sometimes needing lifelong treatment.

Date of knowledge

The point at which you first knew, or ought reasonably to have known, that a significant injury was linked to negligent care. The two-year time limit runs from this date.

Frequently asked questions

Related questions

References

Primary and clinical sources informing this page, accessed June 2026. Legal positions are stated as at June 2026 and depend on individual facts.

1. [01] Irish Cancer Society, Thyroid cancer (accessed June 2026).
2. [02] National Cancer Registry Ireland, Cancer factsheets (incidence, stage and survival, accessed June 2026).
3. [03] HSE National Cancer Control Programme, GP referral guidelines and forms (Rapid Access Clinics for breast, lung, prostate and melanoma, accessed June 2026).
4. [04] European Thyroid Association, EU-TIRADS ultrasound risk stratification (FNA size thresholds, accessed June 2026).
5. [05] Irish thyroid cytology study, repeat fine needle aspiration after benign cytology (accessed June 2026).
6. [06] Courts Service of Ireland, courts.ie judgments (accessed June 2026).
7. [07] Merck Manual Professional, Thyroid cancers (subtypes and survival, accessed June 2026).
8. [08] Judicial Council, Personal Injuries Guidelines 2021 (general damages, accessed June 2026).
9. [09] The Irish Times, Dialysis cancer patients to get life-saving therapy (Cork University Hospital thyroid case, accessed June 2026).
10. [10] Statute of Limitations (Amendment) Act 1991, s.2 (date of knowledge, accessed June 2026).
11. [11] Civil Liability and Courts Act 2004, s.7 (two-year period, accessed June 2026).
12. [12] Government of Ireland, commencement of the Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 (mandatory open disclosure, accessed June 2026).
13. [13] Civil Liability Act 1961, fatal injury provisions and solatium (accessed June 2026).